First Read: Brenntag SE "Q2 profit windfall, FY'26 guidance upgraded" (Neutral)

Research evidence excerpt

First Read: Brenntag SE "Q2 profit windfall, FY'26 guidance upgraded" (Neutral)

Forecast returns

Forecast price appreciation 11.6%

Forecast dividend yield 3.9%

Forecast stock return 15.5%

Market return assumption 7.7%

Forecast excess return 7.9%

Company Description

Brenntag is a third-party B2B distributor of commodity (c70% of FY24 gross profit) and

specialty (c30%) chemicals. Its core business involves purchasing chemicals in truckload-or-

larger quantities and storing them, repackaging these chemicals in smaller amounts, and then

selling them to chemical users, usually in LTL (less-than-truckload) quantities. Brenntag also

provides value-added services, such as just-in-time delivery, reformulating chemicals to

customer requirements, and technical support. Europe (c40% of GP) and North America

(c40%) are the biggest regions, with smaller businesses in APAC and LatAm.

Valuation Method and Risk Statement

Our valuation is based on a DCF methodology, using a WACC of 8.6% and terminal growth

rate of 1.5%. Key upside risks include: EPS accretion from M&A; potential stock re-rating on

acquisition of large Asia Pac targets. Although far less likely, Brenntag has been private

equity-owned in the past, and could be bought out again. Upside risks to conversion margin,

e.g., from EAC acquisition Key downside risks include: FX translation risk (most exposed to

USD:EUR). Stock weakness if management is slow to convert the acquisition pipeline;

concerns regarding value creation if targets are acquired at high multiples; margin dilution

from lower-margin targets; integration and emerging market risk. Regulatory risk relating to

environmental damage, collusive behaviour, or even possible antitrust concerns blocking

M&A.